HB0497 Enrolled LRB096 03560 DRJ 17901 b

1     AN ACT concerning health.
 
2     Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
 
4     Section 5. The Alcoholism and Other Drug Abuse and
5 Dependency Act is amended by adding Section 5-23 as follows:
 
6     (20 ILCS 301/5-23 new)
7     Sec. 5-23. Drug Overdose Prevention Program.
8     (a) Reports of drug overdose.
9         (1) The Director of the Division of Alcoholism and
10     Substance Abuse may publish annually a report on drug
11     overdose trends statewide that reviews State death rates
12     from available data to ascertain changes in the causes or
13     rates of fatal and nonfatal drug overdose for the preceding
14     period of not less than 5 years. The report shall also
15     provide information on interventions that would be
16     effective in reducing the rate of fatal or nonfatal drug
17     overdose.
18         (2) The report may include:
19             (A) Trends in drug overdose death rates.
20             (B) Trends in emergency room utilization related
21         to drug overdose and the cost impact of emergency room
22         utilization.
23             (C) Trends in utilization of pre-hospital and

 

 

HB0497 Enrolled - 2 - LRB096 03560 DRJ 17901 b

1         emergency services and the cost impact of emergency
2         services utilization.
3             (D) Suggested improvements in data collection.
4             (E) A description of other interventions effective
5         in reducing the rate of fatal or nonfatal drug
6         overdose.
7     (b) Programs; drug overdose prevention.
8         (1) The Director may establish a program to provide for
9     the production and publication, in electronic and other
10     formats, of drug overdose prevention, recognition, and
11     response literature. The Director may develop and
12     disseminate curricula for use by professionals,
13     organizations, individuals, or committees interested in
14     the prevention of fatal and nonfatal drug overdose,
15     including, but not limited to, drug users, jail and prison
16     personnel, jail and prison inmates, drug treatment
17     professionals, emergency medical personnel, hospital
18     staff, families and associates of drug users, peace
19     officers, firefighters, public safety officers, needle
20     exchange program staff, and other persons. In addition to
21     information regarding drug overdose prevention,
22     recognition, and response, literature produced by the
23     Department shall stress that drug use remains illegal and
24     highly dangerous and that complete abstinence from illegal
25     drug use is the healthiest choice. The literature shall
26     provide information and resources for substance abuse

 

 

HB0497 Enrolled - 3 - LRB096 03560 DRJ 17901 b

1     treatment.
2         The Director may establish or authorize programs for
3     prescribing, dispensing, or distributing naloxone
4     hydrochloride or any other similarly acting and equally
5     safe drug approved by the U.S. Food and Drug Administration
6     for the treatment of drug overdose. Such programs may
7     include the prescribing of naloxone hydrochloride or any
8     other similarly acting and equally safe drug approved by
9     the U.S. Food and Drug Administration for the treatment of
10     drug overdose to and education about administration by
11     individuals who are not personally at risk of opioid
12     overdose.
13         (2) The Director may provide advice to State and local
14     officials on the growing drug overdose crisis, including
15     the prevalence of drug overdose incidents, trends in drug
16     overdose incidents, and solutions to the drug overdose
17     crisis.
18     (c) Grants.
19         (1) The Director may award grants, in accordance with
20     this subsection, to create or support local drug overdose
21     prevention, recognition, and response projects. Local
22     health departments, correctional institutions, hospitals,
23     universities, community-based organizations, and
24     faith-based organizations may apply to the Department for a
25     grant under this subsection at the time and in the manner
26     the Director prescribes.

 

 

HB0497 Enrolled - 4 - LRB096 03560 DRJ 17901 b

1         (2) In awarding grants, the Director shall consider the
2     necessity for overdose prevention projects in various
3     settings and shall encourage all grant applicants to
4     develop interventions that will be effective and viable in
5     their local areas.
6         (3) The Director shall give preference for grants to
7     proposals that, in addition to providing life-saving
8     interventions and responses, provide information to drug
9     users on how to access drug treatment or other strategies
10     for abstaining from illegal drugs. The Director shall give
11     preference to proposals that include one or more of the
12     following elements:
13             (A) Policies and projects to encourage persons,
14         including drug users, to call 911 when they witness a
15         potentially fatal drug overdose.
16             (B) Drug overdose prevention, recognition, and
17         response education projects in drug treatment centers,
18         outreach programs, and other organizations that work
19         with, or have access to, drug users and their families
20         and communities.
21             (C) Drug overdose recognition and response
22         training, including rescue breathing, in drug
23         treatment centers and for other organizations that
24         work with, or have access to, drug users and their
25         families and communities.
26             (D) The production and distribution of targeted or

 

 

HB0497 Enrolled - 5 - LRB096 03560 DRJ 17901 b

1         mass media materials on drug overdose prevention and
2         response.
3             (E) Prescription and distribution of naloxone
4         hydrochloride or any other similarly acting and
5         equally safe drug approved by the U.S. Food and Drug
6         Administration for the treatment of drug overdose.
7             (F) The institution of education and training
8         projects on drug overdose response and treatment for
9         emergency services and law enforcement personnel.
10             (G) A system of parent, family, and survivor
11         education and mutual support groups.
12         (4) In addition to moneys appropriated by the General
13     Assembly, the Director may seek grants from private
14     foundations, the federal government, and other sources to
15     fund the grants under this Section and to fund an
16     evaluation of the programs supported by the grants.
17     (d) Health care professional prescription of drug overdose
18 treatment medication.
19         (1) A health care professional who, acting in good
20     faith, directly or by standing order, prescribes or
21     dispenses an opioid antidote to a patient who, in the
22     judgment of the health care professional, is capable of
23     administering the drug in an emergency, shall not, as a
24     result of his or her acts or omissions, be subject to
25     disciplinary or other adverse action under the Medical
26     Practice Act of 1987, the Physician Assistant Practice Act

 

 

HB0497 Enrolled - 6 - LRB096 03560 DRJ 17901 b

1     of 1987, the Nurse Practice Act, the Pharmacy Practice Act,
2     or any other professional licensing statute.
3         (2) A person who is not otherwise licensed to
4     administer an opioid antidote may in an emergency
5     administer without fee an opioid antidote if the person has
6     received the patient information specified in paragraph
7     (4) of this subsection and believes in good faith that
8     another person is experiencing a drug overdose. The person
9     shall not, as a result of his or her acts or omissions, be
10     liable for any violation of the Medical Practice Act of
11     1987, the Physician Assistant Practice Act of 1987, the
12     Nurse Practice Act, the Pharmacy Practice Act, or any other
13     professional licensing statute, or subject to any criminal
14     prosecution arising from or related to the unauthorized
15     practice of medicine or the possession of an opioid
16     antidote.
17         (3) A health care professional prescribing an opioid
18     antidote to a patient shall ensure that the patient
19     receives the patient information specified in paragraph
20     (4) of this subsection. Patient information may be provided
21     by the health care professional or a community-based
22     organization, substance abuse program, or other
23     organization with which the health care professional
24     establishes a written agreement that includes a
25     description of how the organization will provide patient
26     information, how employees or volunteers providing

 

 

HB0497 Enrolled - 7 - LRB096 03560 DRJ 17901 b

1     information will be trained, and standards for documenting
2     the provision of patient information to patients.
3     Provision of patient information shall be documented in the
4     patient's medical record or through similar means as
5     determined by agreement between the health care
6     professional and the organization. The Director of the
7     Division of Alcoholism and Substance Abuse, in
8     consultation with statewide organizations representing
9     physicians, advanced practice nurses, physician
10     assistants, substance abuse programs, and other interested
11     groups, shall develop and disseminate to health care
12     professionals, community-based organizations, substance
13     abuse programs, and other organizations training materials
14     in video, electronic, or other formats to facilitate the
15     provision of such patient information.
16         (4) For the purposes of this subsection:
17         "Opioid antidote" means naloxone hydrochloride or any
18     other similarly acting and equally safe drug approved by
19     the U.S. Food and Drug Administration for the treatment of
20     drug overdose.
21         "Health care professional" means a physician licensed
22     to practice medicine in all its branches, a physician
23     assistant who has been delegated the prescription or
24     dispensation of an opioid antidote by his or her
25     supervising physician, an advanced practice registered
26     nurse who has a written collaborative agreement with a

 

 

HB0497 Enrolled - 8 - LRB096 03560 DRJ 17901 b

1     collaborating physician that authorizes the prescription
2     or dispensation of an opioid antidote, or an advanced
3     practice nurse who practices in a hospital or ambulatory
4     surgical treatment center and possesses appropriate
5     clinical privileges in accordance with the Nurse Practice
6     Act.
7         "Patient" includes a person who is not at risk of
8     opioid overdose but who, in the judgment of the physician,
9     may be in a position to assist another individual during an
10     overdose and who has received patient information as
11     required in paragraph (2) of this subsection on the
12     indications for and administration of an opioid antidote.
13         "Patient information" includes information provided to
14     the patient on drug overdose prevention and recognition;
15     how to perform rescue breathing and resuscitation; opioid
16     antidote dosage and administration; the importance of
17     calling 911; care for the overdose victim after
18     administration of the overdose antidote; and other issues
19     as necessary.
 
20     Section 99. Effective date. This Act takes effect January
21 1, 2010.